Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGT1 | P19440 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7220580 | 1.00 | GGT1 (0.32) | GGT1 | |
| SCHEMBL7225545 | 0.78 | ARG1 (0.45) | GGT1 | |
| SCHEMBL7225543 | 0.78 | ARG1 (0.45) | GGT1 | |
| SCHEMBL7219330 | 0.76 | ARG1 (0.47) | GGT1 | |
| SCHEMBL7219328 | 0.76 | ARG1 (0.47) | GGT1 | |
| SCHEMBL7909629 | 0.76 | ARG1 (0.47) | GGT1 | |
| Hydrochloric Acid SCHEMBL8201266 | 0.76 | ARG1 (0.44) | GGT1 | |
| Hydrochloric Acid SCHEMBL8201268 | 0.76 | ARG1 (0.44) | GGT1 | |
| SCHEMBL31441417 | 0.75 | MEN1 (0.46) | — | |
| SCHEMBL8821869 | 0.71 | BHMT (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6576780-B1 | Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors | GD SEARLE & COMPANY | 2003-06-10 | — | — | US | disclosed |
| US-6207708-B1 | FOR THERAPY AND PROPHYLAXIS OF AUTOIMMUNE AND/OR INFLAMMATORY CONDITIONS AFFECTING THE JOINTS SUCH AS ARTHRITIS, AND INFLAMMATORY BOWEL DISEASE, CARDIVASCULAR ISCHEMIA, DIABETES, CONGESTIVE HEART FAILURE, MYOCARDITIS, ATHEROSCLEROSIS, | G. D. SEARLE & COMPANY | 2001-03-27 | — | — | US | disclosed |
| US-5981511-A | AN ENZYME INHIBITOR FOR REDUCING NITRIC OXIDE, TREATING HYPOTENSION SUCH AS TOXIC SHOCK AND THERAPY WITH CERTAIN CYTOKINES | G.D. SEARLE & CO. (US) | 1999-11-09 | — | — | US | disclosed |